WI
RMD icon

Wintrust Investments’s ResMed RMD Stock Holding History

Wintrust Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$39K Buy
173
+9
+5% +$2.17K 0.03% 294
2024
Q3 		$40K Sell
164
-2,334
-93% -$522K 0.03% 351
2024
Q2 		$478K Sell
2,498
-624
-20% -$127K 0.04% 292
2024
Q1 		$618K Buy
3,122
+388
+14% +$71.1K 0.05% 253
2023
Q4 		$470K Buy
+2,734
New +$420K 0.05% 280

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wintrust Investments's RMD Position: Q4 2024 in Review

Wintrust Investments increased its ResMed (RMD) stake by 5.5% in Q4 2024, buying an estimated $2.17K and bringing the position to 173 shares worth $39K. The position accounts for 0.03% of the portfolio, ranked #294.

Wintrust Investments first reported a position in RMD in Q4 2023 and has held it in 5 quarters since. The position peaked at $618K in Q1 2024. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Wintrust Investments held 173 shares of ResMed worth $39K as of Q4 2024.
  • Wintrust Investments bought 9 ResMed shares in Q4 2024, an estimated $2.17K.
  • ResMed made up 0.03% of Wintrust Investments's portfolio in Q4 2024, its #294 holding.
  • Wintrust Investments first reported a position in ResMed in Q4 2023 and has held it in 5 quarters since.
  • Wintrust Investments's ResMed position peaked at $618K in Q1 2024.
  • 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.